Literature DB >> 21200140

A role for CDK9-cyclin K in maintaining genome integrity.

David S Yu1, David Cortez.   

Abstract

Cyclin-dependent kinase 9 (CDK9), with its cyclin T regulatory subunit, is a component of the positive transcription elongation factor b (P-TEFb) complex, which stimulates transcription elongation and also functions in co-transcriptional histone modification, mRNA processing, and mRNA export. CDK9 also binds to cyclin K but the function of this CDK9-cyclin K complex is less clear. We and others have recently shown that CDK9 functions directly in maintaining genome integrity. This activity is restricted to CDK9-cyclin K. Depletion of CDK9 or its cyclin K but not cyclin T regulatory subunit impairs cell cycle recovery in response to replication stress and induces spontaneous DNA damage in replicating cells. CDK9-cyclin K also interacts with ATR and other DNA damage response and DNA repair proteins. CDK9 accumulates on chromatin and limits the amount of single-stranded DNA in response to replication stress. Collectively, these data are consistent with a model in which CDK9 responds to replication stress by localizing to chromatin to reduce the breakdown of stalled replication forks and promote recovery from replication arrest. The direct role of CDK9-cyclin K in pathways that maintain genome integrity in response to replication stress appear to be evolutionarily conserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200140      PMCID: PMC3048070          DOI: 10.4161/cc.10.1.14364

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  50 in total

1.  ATR regulates fragile site stability.

Authors:  Anne M Casper; Paul Nghiem; Martin F Arlt; Thomas W Glover
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

2.  Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro.

Authors:  Vladimir P Bermudez; Laura A Lindsey-Boltz; Anthony J Cesare; Yoshimasa Maniwa; Jack D Griffith; Jerard Hurwitz; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

3.  Mrc1 is a replication fork component whose phosphorylation in response to DNA replication stress activates Rad53.

Authors:  Alexander J Osborn; Stephen J Elledge
Journal:  Genes Dev       Date:  2003-07-15       Impact factor: 11.361

4.  The transcription elongation factor Bur1-Bur2 interacts with replication protein A and maintains genome stability during replication stress.

Authors:  Emanuel Clausing; Andreas Mayer; Sittinan Chanarat; Barbara Müller; Susanne M Germann; Patrick Cramer; Michael Lisby; Katja Strässer
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

5.  A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.

Authors:  P Wei; M E Garber; S M Fang; W H Fischer; K A Jones
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

6.  A robust toolkit for functional profiling of the yeast genome.

Authors:  Xuewen Pan; Daniel S Yuan; Dong Xiang; Xiaoling Wang; Sharon Sookhai-Mahadeo; Joel S Bader; Philip Hieter; Forrest Spencer; Jef D Boeke
Journal:  Mol Cell       Date:  2004-11-05       Impact factor: 17.970

7.  Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.

Authors:  Lee Zou; Stephen J Elledge
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

Review 8.  Cyclin T: three forms for different roles in physiological and pathological functions.

Authors:  Antonio De Luca; Maria De Falco; Alfonso Baldi; Marco G Paggi
Journal:  J Cell Physiol       Date:  2003-02       Impact factor: 6.384

9.  Replication protein A-mediated recruitment and activation of Rad17 complexes.

Authors:  Lee Zou; Dou Liu; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-06       Impact factor: 11.205

10.  Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity.

Authors:  M C Edwards; C Wong; S J Elledge
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more
  17 in total

1.  Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression.

Authors:  Alireza Baradaran-Heravi; Kyoung Sang Cho; Bas Tolhuis; Mrinmoy Sanyal; Olena Morozova; Marie Morimoto; Leah I Elizondo; Darren Bridgewater; Joanna Lubieniecka; Kimberly Beirnes; Clara Myung; Danny Leung; Hok Khim Fam; Kunho Choi; Yan Huang; Kira Y Dionis; Jonathan Zonana; Kory Keller; Peter Stenzel; Christy Mayfield; Thomas Lücke; Arend Bokenkamp; Marco A Marra; Maarten van Lohuizen; David B Lewis; Chad Shaw; Cornelius F Boerkoel
Journal:  Hum Mol Genet       Date:  2012-02-28       Impact factor: 6.150

2.  ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.

Authors:  Hui Zhang; PamelaSara E Head; Waaqo Daddacha; Seong-Hoon Park; Xingzhe Li; Yunfeng Pan; Matthew Z Madden; Duc M Duong; Maohua Xie; Bing Yu; Matthew D Warren; Elaine A Liu; Vishal R Dhere; Chunyang Li; Ivan Pradilla; Mylin A Torres; Ya Wang; William S Dynan; Paul W Doetsch; Xingming Deng; Nicholas T Seyfried; David Gius; David S Yu
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

3.  Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.

Authors:  Yu-Yi Chu; Mei-Kuang Chen; Yongkun Wei; Heng-Huan Lee; Weiya Xia; Ying-Nai Wang; Clinton Yam; Jennifer L Hsu; Hung-Ling Wang; Wei-Chao Chang; Hirohito Yamaguchi; Zhou Jiang; Chunxiao Liu; Ching-Fei Li; Lei Nie; Li-Chuan Chan; Yuan Gao; Shao-Chun Wang; Jinsong Liu; Shannon N Westin; Sanghoon Lee; Anil K Sood; Liuqing Yang; Gabriel N Hortobagyi; Dihua Yu; Mien-Chie Hung
Journal:  Nat Cancer       Date:  2022-10-17

4.  SIRT2 directs the replication stress response through CDK9 deacetylation.

Authors:  Hui Zhang; Seong-Hoon Park; Brooke G Pantazides; Oleksandra Karpiuk; Matthew D Warren; Claire W Hardy; Duc M Duong; So-Jeong Park; Hyun-Seok Kim; Athanassios Vassilopoulos; Nicholas T Seyfried; Steven A Johnsen; David Gius; David S Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

5.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.

Authors:  Dalibor Blazek; Jiri Kohoutek; Koen Bartholomeeusen; Eric Johansen; Petra Hulinkova; Zeping Luo; Peter Cimermancic; Jernej Ule; B Matija Peterlin
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

6.  One stone, two birds: CDK9-directed activation of UBE2A regulates monoubiquitination of both H2B and PCNA.

Authors:  Hui Zhang; David S Yu
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

7.  Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1.

Authors:  Rajesh Ramakrishnan; Wendong Yu; Andrew P Rice
Journal:  BMC Res Notes       Date:  2011-07-26

8.  Complex effects of flavopiridol on the expression of primary response genes.

Authors:  Havva Keskin; Judit Garriga; Daphne Georlette; Xavier Graña
Journal:  Cell Div       Date:  2012-03-29       Impact factor: 5.130

9.  Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax.

Authors:  Hannah M King; Sandeep Rana; Sydney P Kubica; Jayapal Reddy Mallareddy; Smitha Kizhake; Edward L Ezell; Muhammad Zahid; Michael J Naldrett; Sophie Alvarez; Henry C-H Law; Nicholas T Woods; Amarnath Natarajan
Journal:  Bioorg Med Chem Lett       Date:  2021-04-23       Impact factor: 2.940

Review 10.  Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target.

Authors:  Vladimír Krystof; Sonja Baumli; Robert Fürst
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.